Ayurcann Holdings Corp
Ayurcann Holdings Corp. provides post-harvest outsourcing solutions to licensed cannabis producers in Canada. The company offers extraction, processing, and co-manufacturing of pharma grade cannabis to produce various derivative cannabis products in the medical and recreational markets. It also manufactures and distributes cannabis products. The company sells product under the Fuego, H&S, and XPL… Read more
Market Cap & Net Worth: Ayurcann Holdings Corp (AYURF)
Ayurcann Holdings Corp (OTCQB:AYURF) has a market capitalization of $3.41 Million ($3.41 Million) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #37958 globally and #12360 in its home market, demonstrating a -15.87% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ayurcann Holdings Corp's stock price $0.02 by its total outstanding shares 194703863 (194.70 Million).
Ayurcann Holdings Corp Market Cap History: 2015 to 2025
Ayurcann Holdings Corp's market capitalization history from 2015 to 2025. Data shows change from $4.67 Million to $3.41 Million (-3.28% CAGR).
Ayurcann Holdings Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ayurcann Holdings Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.11x
Ayurcann Holdings Corp's market cap is 0.11 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $27.47 Million | $7.63 Million | -$278.36K | 3.60x | N/A |
| 2022 | $5.06 Million | $11.08 Million | -$3.09 Million | 0.46x | N/A |
| 2023 | $4.60 Million | $12.49 Million | -$5.31 Million | 0.37x | N/A |
| 2024 | $4.28 Million | $25.16 Million | -$3.97 Million | 0.17x | N/A |
| 2025 | $3.41 Million | $31.11 Million | -$3.49 Million | 0.11x | N/A |
Competitor Companies of AYURF by Market Capitalization
Companies near Ayurcann Holdings Corp in the global market cap rankings as of March 19, 2026.
Key companies related to Ayurcann Holdings Corp by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Ayurcann Holdings Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, Ayurcann Holdings Corp's market cap moved from $4.67 Million to $ 3.41 Million, with a yearly change of -3.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $3.41 Million | -20.45% |
| 2024 | $4.28 Million | -6.78% |
| 2023 | $4.60 Million | -9.23% |
| 2022 | $5.06 Million | -81.57% |
| 2021 | $27.47 Million | +216.37% |
| 2020 | $8.68 Million | +60.43% |
| 2019 | $5.41 Million | 0.00% |
| 2018 | $5.41 Million | -30.50% |
| 2017 | $7.79 Million | +66.67% |
| 2016 | $4.67 Million | 0.00% |
| 2015 | $4.67 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Ayurcann Holdings Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.41 Million USD |
| MoneyControl | $3.41 Million USD |
| MarketWatch | $3.41 Million USD |
| marketcap.company | $3.41 Million USD |
| Reuters | $3.41 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.